Selecting Optimal Treatment in BCG-Unresponsive NMIBC

Opinion
Video

A panel of experts provide clinical insights on factors that inform how they select treatments for patients with BCG-unresponsive non–muscle invasive bladder cancer.

Related Videos
Marc Bjurlin, DO, MSc, FACOS, answers a question during a Zoom video interview
A panel of 4 experts on prostate cancer
Gary D. Steinberg, MD, an expert on bladder cancer
A panel of 5 experts on bladder cancer
A panel of 5 experts on bladder cancer
A panel of 4 experts on prostate cancer
A panel of 4 experts on prostate cancer
A panel of 4 experts on prostate cancer
A panel of 4 experts on prostate cancer
Gary D. Steinberg, MD, an expert on bladder cancer
Related Content
© 2024 MJH Life Sciences

All rights reserved.